Sign In
Buy OM
$4.60
-0.470 (-9.27%)
At Close: Jun 03, 2026
Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
08:30am, Monday, 05'th Feb 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
08:30am, Monday, 08'th Jan 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08:30am, Wednesday, 03'rd Jan 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical to Present at BofA Home Care Conference
04:05pm, Wednesday, 29'th Nov 2023
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
5 Struggling Stocks to Buy at a Discount
11:43am, Saturday, 25'th Nov 2023
These five companies have glimmers of hope that the market has yet to fully recognize. Each is trading at a significant discount to recent highs.
2 of the Cheapest Stocks I Own
06:30am, Thursday, 23'rd Nov 2023
Target has moved past its inventory woes and is showing positive signs. Outset Medical has faced setbacks, but still has a long runway for growth.
Outset Medical, Inc. (OM) Q3 2023 Earnings Call Transcript
10:12pm, Tuesday, 07'th Nov 2023
Outset Medical, Inc. (NASDAQ:OM ) Q3 2023 Earnings Call Transcript November 7, 2023 5:00 PM ET Company Participants Jim Mazzola - VP, IR Leslie Trigg - Chair & CEO Nabeel Ahmed - CFO Conference Call P
After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)
11:26am, Thursday, 02'nd Nov 2023
Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in
Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)
11:19am, Tuesday, 17'th Oct 2023
The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street
Outset Medical analysts slash price objective after multiple missteps
03:42pm, Friday, 13'th Oct 2023
Outset Medical Inc stock was downgraded by BofA Securities analysts to ‘Underperform' from ‘Buy', and its price objective was cut to $3 per share from $32, after the medical technology company rep
Outset Medical stock plunges on revenue hit from FDA warning letter
09:27am, Friday, 13'th Oct 2023
Outset Medical Inc shares sank as much as 40% in pre-market trading on Friday after the medical technology company reported lower-than-expected preliminary third-quarter 2023 revenue of $30.4 million
Why Dialysis Stocks Plunged Today
12:51pm, Wednesday, 11'th Oct 2023
Novo Nordisk shares rallied after it announced it will stop its FLOW trial nearly a year earlier than expected after positive feedback on interim data for semaglutide's ability to treat kidney disease
Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade)
01:50pm, Friday, 06'th Oct 2023
Outset Medical, Inc. is commercializing a new hemodialysis machine for acute care and home settings. The company has reduced guidance due to pulling its TabloCart from the market to obtain 510(k) mark
Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Tuesday, 29'th Aug 2023
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates
07:29pm, Wednesday, 02'nd Aug 2023
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.77 per share a year ago.
